menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Ligand to Acquire APEIRON Biologics AG for $100 Million

    BUSINESSWIRE

    BeiGene and EUSA Pharma announce China NMPA approval of QARZIBA.

    BUSINESSWIRE

    EUSA Pharma and BeiGene Announce Acceptance of a BLA for QARZIBA

    BUSINESSWIRE

    United Therap`s Biological Dinutuximab Receives Approval In US

    FDA

    United Therapeutics Announces Study of Unituxin® for Small Cell Lung Cancer

    PR NEWSWIRE

    SMC endorses EUSA Pharma’s Qarziba

    PHARMA TIMES

    Y-mAbs preps $92M IPO to push lead assets through regulatory filing

    FIERCE BIOTECH

    EUSA Pharma: NICE approves QARZIBA (dinutuximab beta) for neuroblastoma

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.